Clot Management Devices Market Analysis By Product (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis Devices), By End User, And Segment Forecasts 2013 - 2024
The global clot management market was valued at USD 1.26 billion in 2015 and is further expected to reach a value of USD 1.88 billion by 2024, according to a new report by Grand View Research, Inc. The market is expected to grow with a CAGR of 4.6% owing to the key drivers such as increasing prevalence of stroke, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), obesity, growing geriatric population, technological advancements, and improvement in health insurance coverage & availability of emergency medical services.
Globally, the number of people impacted by PE and DVT, which are collectively known as Venous Thromboembolism (VTE), is much larger than AIDS, cancer, and road traffic accidents combined together.
The data published by the U.S. CDC indicates that stroke is amongst the leading cause of disabilities and is the fifth leading cause of deaths in the U.S. According to the estimates of CDC, PE and DVT affect nearly 900,000 people in the U.S. Furthermore, the CDC estimates also suggest the following:
Approximately 60,000 to 100,000 Americans die due to VTE and nearly 10% to 30% of the people are expected to die within 1 month of their diagnosis
Nearly 33% of the people with VTE will have a recurrence within 10 years
In the U.S.,VTE accounts for over USD 10 billion in medical costs
The various risk factors that lead to VTE and stroke are classified as high, medium, and other risks. The high risk factors include hospitalization; spinal, hip, knee, & cancer surgeries; and inactivity for long time due to various reasons, such as postsurgery, sedentary lifestyle, etc. The moderate risk factors include age above 60 years, family history of blood clots, chemotherapy, and excessive use of estrogen-based medications. The other risk factors include obesity, pregnancy, smoking, and alcohol consumption.
The clot management devices market is also anticipated to grow due to technological advancements and the launch of new-generation thrombectomy devices, such as Penumbra’s AC68 Reperfusion Catheter; Trevo clot retrieval device manufactured by the Concentric Medical, Inc.; and EmboTrap II Revascularization Device manufactured by Neuravi.
Further Key Findings from the Study Suggest:
In 2015, percutaneous thrombectomy devices accounted for the maximum share of over 35%. However, the neurovascular embolectomy devices segment is expected to register the maximum CAGR of 6.2% over the forecast period
Hospitals accounted for the maximum share of over 80%, as majority of the stroke, DVT, and PE cases are treated in emergency and critical care units. The demand for low-risk clot removal procedures is anticipated to drive the diagnostic center segment.
In 2015, North America held the majority revenue share of over 60.5%. The growing awareness about DVT/PE, access to advanced healthcare facilities, and presence of robust reimbursement and regulatory framework are some of the key reasons attributed to the high market share.
Asia Pacific is anticipated to be the fastest growing region with a CAGR of 5.7% over the forecast period.
Some of the key players in the clot management devices market include Boston Scientific Corporation; Edwards Lifesciences; Teleflex; Vascular Solutions, Inc.; Straub Medical; LeMaitre Vascular; Medtronic; iVascular; and others
Globally, the number of people impacted by PE and DVT, which are collectively known as Venous Thromboembolism (VTE), is much larger than AIDS, cancer, and road traffic accidents combined together.
The data published by the U.S. CDC indicates that stroke is amongst the leading cause of disabilities and is the fifth leading cause of deaths in the U.S. According to the estimates of CDC, PE and DVT affect nearly 900,000 people in the U.S. Furthermore, the CDC estimates also suggest the following:
Approximately 60,000 to 100,000 Americans die due to VTE and nearly 10% to 30% of the people are expected to die within 1 month of their diagnosis
Nearly 33% of the people with VTE will have a recurrence within 10 years
In the U.S.,VTE accounts for over USD 10 billion in medical costs
The various risk factors that lead to VTE and stroke are classified as high, medium, and other risks. The high risk factors include hospitalization; spinal, hip, knee, & cancer surgeries; and inactivity for long time due to various reasons, such as postsurgery, sedentary lifestyle, etc. The moderate risk factors include age above 60 years, family history of blood clots, chemotherapy, and excessive use of estrogen-based medications. The other risk factors include obesity, pregnancy, smoking, and alcohol consumption.
The clot management devices market is also anticipated to grow due to technological advancements and the launch of new-generation thrombectomy devices, such as Penumbra’s AC68 Reperfusion Catheter; Trevo clot retrieval device manufactured by the Concentric Medical, Inc.; and EmboTrap II Revascularization Device manufactured by Neuravi.
Further Key Findings from the Study Suggest:
In 2015, percutaneous thrombectomy devices accounted for the maximum share of over 35%. However, the neurovascular embolectomy devices segment is expected to register the maximum CAGR of 6.2% over the forecast period
Hospitals accounted for the maximum share of over 80%, as majority of the stroke, DVT, and PE cases are treated in emergency and critical care units. The demand for low-risk clot removal procedures is anticipated to drive the diagnostic center segment.
In 2015, North America held the majority revenue share of over 60.5%. The growing awareness about DVT/PE, access to advanced healthcare facilities, and presence of robust reimbursement and regulatory framework are some of the key reasons attributed to the high market share.
Asia Pacific is anticipated to be the fastest growing region with a CAGR of 5.7% over the forecast period.
Some of the key players in the clot management devices market include Boston Scientific Corporation; Edwards Lifesciences; Teleflex; Vascular Solutions, Inc.; Straub Medical; LeMaitre Vascular; Medtronic; iVascular; and others
CHAPTER 1 RESEARCH METHODOLOGY
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET SNAPSHOT
CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE
4.1 Market Segmentation & Scope
4.1.1 Market driver analysis
4.1.2 Market restraint analysis
4.2 Penetration & Growth Prospect Mapping
4.3 Clot Management Devices- SWOT Analysis, By Factor (political & legal, economic and technological)
4.4 Industry Analysis - Porter’s
CHAPTER 5 MARKET CATEGORIZATION 1: PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Clot Management Devices Market: Product Movement Analysis
5.2 Neurovascular Embolectomy Devices
5.2.1 Neurovascular embolectomy devices market estimates and forecasts, 2013 - 2024 (USD Million)
5.3 Embolectomy Balloon Catheters
5.3.1 Embolectomy balloon catheters market estimates and forecasts, 2013 - 2024 (USD Million)
5.4 Percutaneous Thrombectomy Devices
5.4.1 Percutaneous thrombectomy devices market estimates and forecasts, 2013 - 2024 (USD Million)
5.5 Catheter-Directed Thrombolysis (CDT) Devices
5.5.1 Catheter-directed thrombolysis (CDT) devices market estimates and forecasts, 2013 - 2024 (USD Million)
5.6 Inferior Vena Cava Filters (IVCF)
5.6.1 Inferior vena cava filters (IVCF) devices market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 6 MARKET CATEGORIZATION 2: END-USE ESTIMATES & TREND ANALYSIS
6.1 Clot Management Devices Market: End-use Movement Analysis
6.2 Diagnostic Centers
6.2.1 Diagnostic centers market estimates and forecasts, 2013 - 2024 (USD Million)
6.3 Hospitals
6.3.1 Hospitals market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 7 MARKET CATEGORIZATION 3: REGIONAL ESTIMATES & TREND ANALYSIS, BY PRODUCT & END-USE
7.1 Clot Management Devices Market Share by Region, 2013 & 2024
7.2 North America
7.2.1 North America clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.2.3 Canada
7.2.3.1 Canada clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.3 Europe
7.3.1 Europe clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.3.2 Germany
7.3.2.1 Germany clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.3.3 UK
7.3.3.1 UK clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.4.2 Japan
7.4.2.1 Japan clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.4.3 China
7.4.3.1 China clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.5 Latin America
7.5.1 Latin America clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.6 MEA
7.6.1 MEA clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Medtronic
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Boston Scientific Corporation
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 iVascular SLU
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Teleflex Inc.
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 Edwards Lifesciences Corporation
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 LeMaitre Vascular, Inc.
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 Vascular Solutions, Inc.;
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 Straub Medical AG
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 Cook Medical
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives
8.10 DePuy Synthes
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET SNAPSHOT
CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE
4.1 Market Segmentation & Scope
4.1.1 Market driver analysis
4.1.2 Market restraint analysis
4.2 Penetration & Growth Prospect Mapping
4.3 Clot Management Devices- SWOT Analysis, By Factor (political & legal, economic and technological)
4.4 Industry Analysis - Porter’s
CHAPTER 5 MARKET CATEGORIZATION 1: PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Clot Management Devices Market: Product Movement Analysis
5.2 Neurovascular Embolectomy Devices
5.2.1 Neurovascular embolectomy devices market estimates and forecasts, 2013 - 2024 (USD Million)
5.3 Embolectomy Balloon Catheters
5.3.1 Embolectomy balloon catheters market estimates and forecasts, 2013 - 2024 (USD Million)
5.4 Percutaneous Thrombectomy Devices
5.4.1 Percutaneous thrombectomy devices market estimates and forecasts, 2013 - 2024 (USD Million)
5.5 Catheter-Directed Thrombolysis (CDT) Devices
5.5.1 Catheter-directed thrombolysis (CDT) devices market estimates and forecasts, 2013 - 2024 (USD Million)
5.6 Inferior Vena Cava Filters (IVCF)
5.6.1 Inferior vena cava filters (IVCF) devices market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 6 MARKET CATEGORIZATION 2: END-USE ESTIMATES & TREND ANALYSIS
6.1 Clot Management Devices Market: End-use Movement Analysis
6.2 Diagnostic Centers
6.2.1 Diagnostic centers market estimates and forecasts, 2013 - 2024 (USD Million)
6.3 Hospitals
6.3.1 Hospitals market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 7 MARKET CATEGORIZATION 3: REGIONAL ESTIMATES & TREND ANALYSIS, BY PRODUCT & END-USE
7.1 Clot Management Devices Market Share by Region, 2013 & 2024
7.2 North America
7.2.1 North America clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.2.3 Canada
7.2.3.1 Canada clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.3 Europe
7.3.1 Europe clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.3.2 Germany
7.3.2.1 Germany clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.3.3 UK
7.3.3.1 UK clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.4.2 Japan
7.4.2.1 Japan clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.4.3 China
7.4.3.1 China clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.5 Latin America
7.5.1 Latin America clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.6 MEA
7.6.1 MEA clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Medtronic
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Boston Scientific Corporation
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 iVascular SLU
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Teleflex Inc.
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 Edwards Lifesciences Corporation
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 LeMaitre Vascular, Inc.
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 Vascular Solutions, Inc.;
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 Straub Medical AG
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 Cook Medical
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives
8.10 DePuy Synthes
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives
LIST OF TABLES
TABLE 1 Global clot management devices market revenue, by product, 2013 - 2024 (USD Million) 14
TABLE 2 Global clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 3 Global clot management devices market revenue, by region, 2013 - 2024 (USD Million)
TABLE 4 North America clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 5 North America clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 6 U.S. clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 7 U.S. clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 8 Canada clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 9 Canada clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 10 Europe clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 11 Europe clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 12 Germany clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 13 Germany clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 14 UK clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 15 UK clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 16 Asia Pacific clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 17 Asia Pacific clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 18 Japan clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 19 Japan clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 20 China clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 21 China clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 22 Latin America clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 23 Latin America clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 24 Brazil clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 25 Brazil clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 26 Mexico clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 27 Mexico clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 28 MEA clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 29 MEA clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 30 South Africa clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 31 South Africa clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 1 Global clot management devices market revenue, by product, 2013 - 2024 (USD Million) 14
TABLE 2 Global clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 3 Global clot management devices market revenue, by region, 2013 - 2024 (USD Million)
TABLE 4 North America clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 5 North America clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 6 U.S. clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 7 U.S. clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 8 Canada clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 9 Canada clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 10 Europe clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 11 Europe clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 12 Germany clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 13 Germany clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 14 UK clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 15 UK clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 16 Asia Pacific clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 17 Asia Pacific clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 18 Japan clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 19 Japan clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 20 China clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 21 China clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 22 Latin America clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 23 Latin America clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 24 Brazil clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 25 Brazil clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 26 Mexico clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 27 Mexico clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 28 MEA clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 29 MEA clot management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 30 South Africa clot management devices market, by product, 2013 - 2024 (USD Million)
TABLE 31 South Africa clot management devices market, by end-use, 2013 - 2024 (USD Million)
LIST OF FIGURES
FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Clot management devices market: Product outlook key takeaways
FIG. 10 Clot management devices market: Product movement analysis
FIG. 11 Global neurovascular embolectomy devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 12 Global embolectomy balloon catheters market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 13 Global percutaneous thrombectomy devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 14 Global catheter-directed thrombolysis (CDT) devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 15 Global inferior vena cava filters (IVCF) market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 16 Clot management devices market:End-use outlook key takeaways
FIG. 17 Clot management devices market: End-use movement analysis
FIG. 18 Global diagnostic centers market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 19 Global hospitals markete stimates and forecasts, 2013 - 2024 (USD Million)
FIG. 20 Regional market place: key takeaways
FIG. 21 Regional outlook, 2015 & 2024
FIG. 22 North America clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 23 U.S. clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 24 Canada clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 25 Europe clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 26 Germany clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 27 UK clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 28 Asia Pacific clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 29 Japan clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 30 China clot management devices market estimates, by product, 2013 - 2015 (USD Million)
FIG. 31 Latin America clot management devices market estimates, by product, 2013 - 2015 (USD Million)
FIG. 32 Brazil clot management devices market estimates, by product, 2013 - 2015 (USD Million)
FIG. 33 Mexico clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 34 MEA clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 35 South Africa clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Clot management devices market: Product outlook key takeaways
FIG. 10 Clot management devices market: Product movement analysis
FIG. 11 Global neurovascular embolectomy devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 12 Global embolectomy balloon catheters market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 13 Global percutaneous thrombectomy devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 14 Global catheter-directed thrombolysis (CDT) devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 15 Global inferior vena cava filters (IVCF) market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 16 Clot management devices market:End-use outlook key takeaways
FIG. 17 Clot management devices market: End-use movement analysis
FIG. 18 Global diagnostic centers market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 19 Global hospitals markete stimates and forecasts, 2013 - 2024 (USD Million)
FIG. 20 Regional market place: key takeaways
FIG. 21 Regional outlook, 2015 & 2024
FIG. 22 North America clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 23 U.S. clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 24 Canada clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 25 Europe clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 26 Germany clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 27 UK clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 28 Asia Pacific clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 29 Japan clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 30 China clot management devices market estimates, by product, 2013 - 2015 (USD Million)
FIG. 31 Latin America clot management devices market estimates, by product, 2013 - 2015 (USD Million)
FIG. 32 Brazil clot management devices market estimates, by product, 2013 - 2015 (USD Million)
FIG. 33 Mexico clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 34 MEA clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 35 South Africa clot management devices market estimates and forecasts, 2013 - 2024 (USD Million)
